Curative Biotechnology Inc Cash Flow-to-Debt Ratio
Curative Biotechnology Inc cash flow-to-debt ratio. Curative Biotechnology Inc (CUBT) has a Cash Flow-to-Debt Ratio of -0.02x as of March 2026, meaning its operating cash flow of $-193.12K could theoretically repay 0% of its total liabilities ($8.37 Million) in one year. Check how high is Curative Biotechnology Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Curative Biotechnology Inc (2013–2025)
Cash flow-to-debt ratio of Curative Biotechnology Inc from 2013 to 2025. Historical debt coverage capacity for Curative Biotechnology Inc across 13 annual periods. Check CUBT total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Curative Biotechnology Inc Cash Flow-to-Debt Ratio by Year (2013–2025)
Curative Biotechnology Inc cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Curative Biotechnology Inc. For the full cash flow conversion analysis, see how efficiently does Curative Biotechnology Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.11x | $-868.87K | $8.20 Million | ▲ +26.7% |
| 2024 | -0.14x | $-1.02 Million | $7.08 Million | ▼ -70.7% |
| 2023 | -0.08x | $-486.58K | $5.75 Million | ▼ -24.7% |
| 2022 | -0.07x | $-1.54 Million | $22.62 Million | ▲ +20.5% |
| 2021 | -0.09x | $-1.60 Million | $18.77 Million | ▼ -205.4% |
| 2020 | -0.03x | $-190.09K | $6.80 Million | ▼ -7305.3% |
| 2019 | 0.00x | $-150.00 | $397.10K | ▼ -84.9% |
| 2018 | 0.00x | $-150.00 | $734.36K | ▲ +2.2% |
| 2017 | 0.00x | $-150.00 | $718.33K | ▲ +97.5% |
| 2016 | -0.01x | $-5.89K | $702.29K | ▼ -394.8% |
| 2015 | 0.00x | $1.96K | $687.16K | ▲ +113.0% |
| 2014 | -0.02x | $-20.99K | $960.99K | ▲ +42.9% |
| 2013 | -0.04x | $-35.68K | $932.66K | — |